These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11786316)

  • 1. Neurotensin: an endogenous antipsychotic?
    Kinkead B; Nemeroff CB
    Curr Opin Pharmacol; 2002 Feb; 2(1):99-103. PubMed ID: 11786316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel treatments of schizophrenia: targeting the neurotensin system.
    Kinkead B; Nemeroff CB
    CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin: an endogenous psychostimulant?
    Bérod A; Rostène W
    Curr Opin Pharmacol; 2002 Feb; 2(1):93-8. PubMed ID: 11786315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF neurotensin concentrations and antipsychotic treatment in schizophrenia and schizoaffective disorder.
    Sharma RP; Janicak PG; Bissette G; Nemeroff CB
    Am J Psychiatry; 1997 Jul; 154(7):1019-21. PubMed ID: 9210757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin agonists: potential in the treatment of schizophrenia.
    Boules M; Shaw A; Fredrickson P; Richelson E
    CNS Drugs; 2007; 21(1):13-23. PubMed ID: 17190526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
    Stowe ZN; Bissette G; Nemeroff CB
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
    Cáceda R; Kinkead B; Nemeroff CB
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin, schizophrenia, and antipsychotic drug action.
    Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
    Kinkead B; Nemeroff CB
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin analogs indications for use as potential antipsychotic compounds.
    McMahon BM; Boules M; Warrington L; Richelson E
    Life Sci; 2002 Jan; 70(10):1101-19. PubMed ID: 11848295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward.
    Rompré PP
    Peptides; 1995; 16(8):1417-20. PubMed ID: 8745052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin agonists as an alternative to antipsychotics.
    Boules M; Fredrickson P; Richelson E
    Expert Opin Investig Drugs; 2005 Apr; 14(4):359-69. PubMed ID: 15882113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
    Griebel G
    Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies.
    Nemeroff CB; Levant B; Myers B; Bissette G
    Ann N Y Acad Sci; 1992; 668():146-56. PubMed ID: 1361110
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin receptor agonists and antagonists for schizophrenia.
    Richelson E; Fredrickson PA; Boules MM
    Am J Psychiatry; 2005 Mar; 162(3):633-4; author reply 635. PubMed ID: 15741499
    [No Abstract]   [Full Text] [Related]  

  • 18. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 19. Antipsychotics and neuropeptides: the atypical profile of CI-943 and its relationship to neurotensin.
    Liégeois JF; Bonaventure P; Delarge J; Damas J
    Neurosci Biobehav Rev; 1995; 19(4):519-31. PubMed ID: 8684714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.